NCT04258774

Brief Summary

The purpose of this research study is to better understand how blood flow and metabolism are different between normal controls and patients with disease. The investigators will examine brain blood flow and metabolism using magnetic resonance imaging (MRI). The brain's blood vessels expand and constrict to regulate blood flow based on the brain's needs. The amount of expanding and contracting the blood vessels can do varies by age. The brain's blood flow changes in small ways during everyday activities, such as normal brain growth, exercise, or deep concentration. Significant illness or physiologic stress may increase the brain's metabolic demand or cause other bigger changes in blood flow. If blood vessels are not able to expand to give more blood flow when metabolic demand is high, the brain may not get all of the oxygen it needs. In less extreme circumstances, not having as much oxygen as it wants may cause the brain to grow and develop more slowly than it should. One way to test the ability of the blood vessels to expand is by measuring blood flow while breathing in carbon dioxide (CO2). CO2 causes blood vessels in the brain to dilate without increasing brain metabolism. The study team will use a special mask to control the amount of oxygen and carbon dioxide patients breath in so that we can study how their brain reacts to these changes. This device designed to simulate carbon dioxide levels achieved by a breath-hold and target the concentration of carbon dioxide in the blood in breathing patients. The device captures exhaled gas and provides an admixture of fresh gas and neutral/expired gas to target different carbon dioxide levels while maintaining a fixed oxygen level. The study team will obtain MRI images of the brain while the subjects are breathing air controlled by the device.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
20mo left

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Jan 2020Dec 2027

Study Start

First participant enrolled

January 29, 2020

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

February 3, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 6, 2020

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

January 16, 2026

Status Verified

January 1, 2026

Enrollment Period

7.9 years

First QC Date

February 3, 2020

Last Update Submit

January 14, 2026

Conditions

Keywords

brain metabolismoxygen extraction fractioncerebral vascular reactivitycarbon dioxide

Outcome Measures

Primary Outcomes (1)

  • Cerebral Oxygen Metabolism

    From the beginning of the MRI scan to the completion of the MRI scan -- 75 minutes.

Secondary Outcomes (1)

  • Cerebrovascular Reactivity

    From administration of carbon dioxide to end of inhalation of carbon dioxide -- 15 minutes.

Study Arms (2)

Healthy Adults

ACTIVE COMPARATOR
Other: Carbon Dioxide

Adults diagnosed with vascular pathology of the brain

ACTIVE COMPARATOR
Other: Carbon Dioxide

Interventions

The study team will administer inhaled carbon dioxide to the participants during an MRI at a level

Adults diagnosed with vascular pathology of the brainHealthy Adults

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adult subjects (\>18 years old) OR adult patients (\>18 years old) diagnosed with vascular pathology of the brain willing to participate and sign a consent form.
  • Able to participate in MRI scan without sedation
  • Not on stimulant medications
  • No psychiatric history, as defined by seeing a psychiatrist for medical evaluation and treatment, or taking anti-depressant medications
  • No seizure history
  • May have occasional headaches if not taking a daily preventative medication for headaches
  • Not on vasodilatory medication, such as sildenafil or verapamil

You may not qualify if:

  • Subjects refusing to undergo testing
  • Subjects with obstructive or resistive lung disease whose PaCO2 at rest is greater than 50mmHg or whose venous serum bicarbonate is greater than 26 mEq/L
  • Subjects with pre-existing respiratory or metabolic acidosis
  • Subjects who require portable oxygen at rest or with exercise
  • Subjects with chronic heart failure or severe pulmonary disease who are unable to climb one flight of stairs due to shortness of breath
  • Subjects with severe heart failure or restrictive lung disease with resting respiratory rate over 15 breaths/min 2. Patients that cannot participate in a course of rehabilitation therapy.
  • Subjects that cannot undergo an MRI scan due to one of the following indications:
  • Pregnancy
  • Obtundation, or Coma
  • Confusion, Delirium, or Dementia
  • Unable to understand or carry out commands regarding keeping still and breathing pattern
  • Increased intracranial pressure due to space occupying lesion or obstruction of outflow of CSF
  • Claustrophobia
  • History of kidney problems
  • Pace makers
  • +12 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University of St. Louis

St Louis, Missouri, 63110, United States

Location

MeSH Terms

Conditions

Hypoxia, BrainHyperoxiaHypercapniaHypocapnia

Interventions

Carbon Dioxide

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Carbon Compounds, InorganicInorganic ChemicalsGasesOxidesOxygen Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: All arms will receive the same study conditions.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 3, 2020

First Posted

February 6, 2020

Study Start

January 29, 2020

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

January 16, 2026

Record last verified: 2026-01

Locations